학술논문
Access in all areas? A round up of developments in market access and health technology assessment: part 3
Document Type
article
Source
Journal of Comparative Effectiveness Research, Vol 13, Iss 3 (2024)
Subject
Language
English
ISSN
2042-6313
Abstract
In this latest update, we explore some of the key updates in market access over recent months including the UK’s voluntary scheme for branded medicines pricing, access and growth (VPAG), the first drugs funded by the Innovative Medicines Fund in the UK and the Direct Access Scheme in France, and, finally, the new Institute for Clinical and Economic Review (ICER) value assessment framework in the USA.